Skip to main content
The Markets by Proactive
Go to Proactive UK

Pharma & Biotech

FIVE at FIVE: GSK, AstraZeneca plummet; LandSec profits; Economy stalls; FTSE 100 meanders; TT snubs Volex

1. Trump anti-vax health appointment wipes £7bn from AstraZeneca and GSK

President-elect Donald Trump announced the controversial appointment of Robert F Kennedy Junior, an outward anti-vaxer, on Thursday.

Read more

2. LandSec still trailing profit targets despite marked improvement

LandSec delivered a 3.9% total return on equity, which represents the profitability for shareholders’ contributions, in the period.

Read more

3. UK recovery 'running out of steam' after economy barely grew pre-Budget - analysts

Office for National Statistics figures on Friday showed the UK economy expanded by 0.1% in the third quarter, against the 0.5% growth seen over the second and below the 0.2% expected by analysts.

Read more

4. FTSE 100 Live

Stocks stay put.

Read more

5. Volex tables bid for TT Electronics, accuses board of ‘execution missteps’

According to Volex, TT’s board has declined to engage with the proposals, despite the bumper premium offered to shareholders.

Read more

In the small-cap space: